Bell Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$106K Sell
301
-10
-3% -$3.56K 0.02% 167
2025
Q4
$102K Buy
311
+47
+18% +$14.9K 0.02% 168
2025
Q3
$74.5K Sell
264
-35
-12% -$10.2K 0.01% 190
2025
Q2
$83.5K Buy
299
+10
+3% +$2.83K 0.01% 182
2025
Q1
$90K Buy
289
+8
+3% +$2.36K 0.02% 154
2024
Q4
$73.2K Sell
281
-3
-1% -$890 0.01% 174
2024
Q3
$91.5K Hold
284
0.02% 152
2024
Q2
$88.7K Sell
284
-9
-3% -$2.64K 0.02% 150
2024
Q1
$83.3K Sell
293
-2
-0.7% -$585 0.02% 153
2023
Q4
$85K Buy
295
+2
+0.7% +$545 0.02% 149
2023
Q3
$78.7K Buy
293
+52
+22% +$13K 0.02% 140
2023
Q2
$53.5K Sell
241
-44
-15% -$10.2K 0.01% 157
2023
Q1
$68.9K Buy
285
+1
+0.4% +$245 0.02% 137
2022
Q4
$74.6K Buy
284
+50
+21% +$13.4K 0.02% 125
2022
Q3
$53K Sell
234
-67
-22% -$16.2K 0.02% 130
2022
Q2
$73K Buy
+301
New +$73.8K 0.02% 103
2021
Q4
$58K Buy
260
+14
+6% +$2.96K 0.02% 142
2021
Q3
$52K Buy
+246
New +$56.6K 0.02% 138

Other funds holding AMGN

Bell Investment Advisors's AMGN Position: Q1 2026 in Review

Bell Investment Advisors reduced its Amgen (AMGN) stake by 3.2% in Q1 2026, selling an estimated $3.56K and leaving 301 shares worth $106K. The position accounts for 0.02% of the portfolio, ranked #167.

Bell Investment Advisors first reported a position in AMGN in Q3 2021 and has held it in 18 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bell Investment Advisors held 301 shares of Amgen worth $106K as of Q1 2026.
  • Bell Investment Advisors sold 10 Amgen shares in Q1 2026, an estimated $3.56K.
  • Amgen made up 0.02% of Bell Investment Advisors's portfolio in Q1 2026, its #167 holding.
  • Bell Investment Advisors first reported a position in Amgen in Q3 2021 and has held it in 18 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bell Investment Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.